Page 47 - Merck Sharp News Today

Merck & Co. Inc is a leading technology and science corporation. Read this to learn more about Merck & Co.'s contracts with the government.

In three separate preliminary rulings delivered by the Court of Justice of the European Union (CJEU) on 17 November 2022 (Novartis v Abacus Medicine, Bayer v kolpharma...

Under two per cent of 2.23 million courses of molnupiravir bought by the Department of Health have ever been prescribed

A higher starting dose of lenvatinib is associated with better health-related quality of life in patients with renal cell carcinoma.

‘Indication creep’ and increasing financial toxicity to patients remain of significant concern, cautions Michelle Kittleson.

Minor changes and additions to annual ACIP recommendations affected vaccines for COVID-19; dengue fever; pneumococcal disease; and measles, mumps, and rubella.

/PRNewswire/ -- Nectin Therapeutics Ltd. (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune...

Wellmarker Bio is pleased to sign a clinical collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA) to evaluate a first-in-class treatment with a novel mechanism in

Leading one of the country’s global pharmaceutical businesses, get to know the Merck & Co. Inc. leaders and executives behind its success.

Merck is a multinational pharmaceutical company with several contracts with the United States government. Take a look at the top Merck government contracts.